These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9439554)

  • 21. Metformin in combination with various insulin secretagogues in type 2 diabetes and associated risk of cardiovascular morbidity and mortality--a retrospective nationwide study.
    Mogensen UM; Andersson C; Fosbøl EL; Schramm TK; Vaag A; Scheller NM; Torp-Pedersen C; Gislason G; Køber L
    Diabetes Res Clin Pract; 2015 Jan; 107(1):104-12. PubMed ID: 25458330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of natural antioxidants on in vitro lipoprotein oxidation.
    Dobreanu M; Módy E
    Rom J Intern Med; 1997; 35(1-4):55-62. PubMed ID: 9562653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of gliclazide--a new antidiabetic agent--on blood platelet function in vitro and in vivo.
    Arfors KE; Bergqvist D; Tangen O
    Ups J Med Sci; 1980; 85(1):74-83. PubMed ID: 7385462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of gliquidone, glibenclamide, gliclazide and glipizide in middle-aged and aged subjects.
    Courtois P; Sener A; Herbaut C; Turc A; Malaisse WJ
    Res Commun Mol Pathol Pharmacol; 1999 Feb; 103(2):211-22. PubMed ID: 10461687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The place of gliclazide MR in the evolving type 2 diabetes landscape: A comparison with other sulfonylureas and newer oral antihyperglycemic agents.
    Colagiuri S; Matthews D; Leiter LA; Chan SP; Sesti G; Marre M
    Diabetes Res Clin Pract; 2018 Sep; 143():1-14. PubMed ID: 29802958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Divergent cardiac effects of the first and second generation hypoglycemic sulfonylurea compounds.
    Ballagi-Pordány G; Köszeghy A; Koltai MZ; Aranyi Z; Pogátsa G
    Diabetes Res Clin Pract; 1990 Jan; 8(2):109-14. PubMed ID: 2106423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antioxidant nutrient supplementation reduces the susceptibility of low density lipoprotein to oxidation in patients with coronary artery disease.
    Mosca L; Rubenfire M; Mandel C; Rock C; Tarshis T; Tsai A; Pearson T
    J Am Coll Cardiol; 1997 Aug; 30(2):392-9. PubMed ID: 9247510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential effect of sulfonylureas on production of reactive oxygen species and apoptosis in cultured pancreatic beta-cell line, MIN6.
    Sawada F; Inoguchi T; Tsubouchi H; Sasaki S; Fujii M; Maeda Y; Morinaga H; Nomura M; Kobayashi K; Takayanagi R
    Metabolism; 2008 Aug; 57(8):1038-45. PubMed ID: 18640379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacogenomic analysis of ATP-sensitive potassium channels coexpressing the common type 2 diabetes risk variants E23K and S1369A.
    Lang VY; Fatehi M; Light PE
    Pharmacogenet Genomics; 2012 Mar; 22(3):206-14. PubMed ID: 22209866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dose-response relationship between sulfonylureas and major adverse cardiovascular events in elderly patients with type 2 diabetes.
    Abdelmoneim AS; Eurich DT; Senthilselvan A; Qiu W; Simpson SH
    Pharmacoepidemiol Drug Saf; 2016 Oct; 25(10):1186-1195. PubMed ID: 27102581
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Troglitazone increases the resistance of low density lipoprotein to oxidation in healthy volunteers.
    Cominacini L; Young MM; Capriati A; Garbin U; Fratta Pasini A; Campagnola M; Davoli A; Rigoni A; Contessi GB; Lo Cascio V
    Diabetologia; 1997 Oct; 40(10):1211-8. PubMed ID: 9349604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antioxidant and vascular effects of gliclazide in type 2 diabetic rats fed high-fat diet.
    Sena CM; Louro T; Matafome P; Nunes E; Monteiro P; Seiça R
    Physiol Res; 2009; 58(2):203-209. PubMed ID: 18380531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gliclazide scavenges hydroxyl and superoxide radicals: an electron spin resonance study.
    Noda Y; Mori A; Cossins E; Packer L
    Metabolism; 2000 Feb; 49(2 Suppl 1):14-6. PubMed ID: 10693914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sulfonylureas induce cholesterol accumulation in cultured human intimal cells and macrophages.
    Sobenin IA; Maksumova MA; Slavina ES; Balabolkin MI; Orekhov AN
    Atherosclerosis; 1994 Feb; 105(2):159-63. PubMed ID: 8003091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oxidized low-density lipoproteins and endothelium: oral vitamin E supplementation prevents oxidized low-density lipoprotein-mediated vascular injury.
    Balla J; Belcher JD; Balla G; Jacob HS; Vercellotti GM
    Trans Assoc Am Physicians; 1993; 106():128-33. PubMed ID: 8036736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug interactions of gliclazide and other sulfonylureas in protein binding in vitro and in hypoglycemic effect in rats.
    Fujii T; Nakamura K; Furukawa H; Watanabe M; Kuwashima J; Miyazaki H; Kawashima K; Kuzuya T
    Arzneimittelforschung; 1983; 33(11):1535-7. PubMed ID: 6686448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adverse cardiovascular events during treatment with glyburide (glibenclamide) or gliclazide in a high-risk population.
    Juurlink DN; Gomes T; Shah BR; Mamdani MM
    Diabet Med; 2012 Dec; 29(12):1524-8. PubMed ID: 22913620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of ascorbate supplementation on low density lipoprotein oxidation in smokers.
    Fuller CJ; Grundy SM; Norkus EP; Jialal I
    Atherosclerosis; 1996 Jan; 119(2):139-50. PubMed ID: 8808491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular effects of conventional sulfonylureas and glimepiride.
    Geisen K; Végh A; Krause E; Papp JG
    Horm Metab Res; 1996 Sep; 28(9):496-507. PubMed ID: 8911987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased oxidation resistance of atherogenic plasma lipoproteins at high vitamin E levels in non-vitamin E supplemented men.
    Porkkala-Sarataho E; Nyyssönen K; Salonen JT
    Atherosclerosis; 1996 Jul; 124(1):83-94. PubMed ID: 8800496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.